Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lifogesic Strong is a topical analgesic spray developed by Intra Life, containing a combination of diclofenac diethylamine (2.32%), methyl salicylate (10%), and linseed oil. Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that acts by inhibiting cyclooxygenase (COX) enzymes, thereby reducing the synthesis of pro-inflammatory prostaglandins. Methyl salicylate and linseed oil serve as counterirritants and penetration enhancers, facilitating the local absorption of diclofenac and providing a soothing effect on the application site. It is primarily indicated for the symptomatic relief of muscle pain, joint pain, and inflammation associated with musculoskeletal disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lifogesic Strong.